The latest closing stock price for ProQR Therapeutics as of November 20, 2024 is 3.67.
An investor who bought $1,000 worth of ProQR Therapeutics stock at the IPO in 2014 would have $-751 today, roughly -1 times their original investment - a -12.97% compound annual growth rate over 10 years.
The all-time high ProQR Therapeutics stock closing price was 24.99 on March 10, 2015.
The ProQR Therapeutics 52-week high stock price is 4.62, which is 25.9% above the current share price.
The ProQR Therapeutics 52-week low stock price is 1.18, which is 67.8% below the current share price.
The average ProQR Therapeutics stock price for the last 52 weeks is 2.15.
An investor who bought $1,000 worth of ProQR Therapeutics stock at the IPO in 2014 would have $-751 today, roughly -1 times their original investment - a -12.97% compound annual growth rate over 10 years.
The all-time high ProQR Therapeutics stock closing price was 24.99 on March 10, 2015.
The ProQR Therapeutics 52-week high stock price is 4.62, which is 25.9% above the current share price.
The ProQR Therapeutics 52-week low stock price is 1.18, which is 67.8% below the current share price.
The average ProQR Therapeutics stock price for the last 52 weeks is 2.15.